FOTS+/TGCT/CSF1+ breast cancers account for 6 to 12% of the cases, whereas FOTS-/TGCT/CSF1- breast cancers account for 41 to 65% of the cases in the four breast cancer datasets (see Additional file 7). This evidence concerns the gene CSF1 and breast cancer.